VTI Life Sciences Competitors

KPMG Taseer Hadi & Co. (KPMG Pakistan) is a member firm of KPMG International, and is part of the Middle East and South Asia (MESA) sub-region of EMA, to respond to an environment requiring the resources of a globally aligned organization combined with detailed knowledge of local laws, regulations, markets and competition. We advise global clients who include many of the worlds leading organizations. We also work with government institutions, national market leaders and other highly respected organizations in key sectors of the Pakistan economy including financial services, energy, chemicals & pharmaceuticals, cement, sugar, oil refining, hotels, electrical & engineering etc. Our industry focus, which is fundamental to our approach, has enabled us to develop in-depth knowledge of our clients businesses and to provide them with an informed perspective on the issues they face. It is a strategy that runs across the full range of services and is underpinned by our global and regional strength. Throughout our practice we have substantial individual and collective experience of serving clients encompassing audit, tax, and advisory services. KPMG Taseer Hadi & Co. in Pakistan embodies the value proposition of KPMG’s global network in providing professional services to organizations in both the public and private sectors which rely on KPMG for the integrity of their audit opinion, the provision of sound and valuable business guidance and advice on potential business risks.

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical andConsulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 22,000+ global employees work in partnership with biopharmaceutical leaders, emerging innovators and sites todesign and deliver clinical trials with patients in mind — broadening access and making clinicalresearch a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’smost complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven deliveryand trustedexecution are accelerating the delivery of life-changingtreatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and2023 Society for Clinical Research Sites Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove any comments that do not adhere to our guidelines as well as report users who violate the rules of our page.